114 related articles for article (PubMed ID: 9177427)
1. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid.
Yaguchi M; Miyazawa K; Katagiri T; Nishimaki J; Kizaki M; Tohyama K; Toyama K
Leukemia; 1997 Jun; 11(6):779-87. PubMed ID: 9177427
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of polyprenylalcohols and vitamin K2 derivatives.
Ishihara M; Takayama F; Toguchi M; Nakano K; Yasumoto E; Nakayachi T; Satoh K; Sakagami H
Anticancer Res; 2000; 20(6B):4307-13. PubMed ID: 11205263
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells.
Sun LK; Yoshii Y; Miyagi K
J Neurooncol; 2000 Mar; 47(1):31-8. PubMed ID: 10930097
[TBL] [Abstract][Full Text] [Related]
4. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody.
Yaguchi M; Miyazawa K; Otawa M; Katagiri T; Nishimaki J; Uchida Y; Iwase O; Gotoh A; Kawanishi Y; Toyama K
Leukemia; 1998 Sep; 12(9):1392-7. PubMed ID: 9737687
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells.
Miyazawa K; Yaguchi M; Funato K; Gotoh A; Kawanishi Y; Nishizawa Y; Yuo A; Ohyashiki K
Leukemia; 2001 Jul; 15(7):1111-7. PubMed ID: 11455981
[TBL] [Abstract][Full Text] [Related]
7. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis.
Manikam SD; Stanslas J
J Pharm Pharmacol; 2009 Jan; 61(1):69-78. PubMed ID: 19126299
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of thrombomodulin antigen levels in U937 cells by combined stimulation with estradiol-17beta and vitamin K2 (menaquinone 4).
Nishiguchi T; Kobayashi T; Sugimura M; Kobayashi H; Terao T
Semin Thromb Hemost; 1999; 25(5):509-17. PubMed ID: 10625211
[TBL] [Abstract][Full Text] [Related]
11. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
12. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
13. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F
Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer.
Yoshida T; Miyazawa K; Kasuga I; Yokoyama T; Minemura K; Ustumi K; Aoshima M; Ohyashiki K
Int J Oncol; 2003 Sep; 23(3):627-32. PubMed ID: 12888897
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation.
Nishimaki J; Miyazawa K; Yaguchi M; Katagiri T; Kawanishi Y; Toyama K; Ohyashiki K; Hashimoto S; Nakaya K; Takiguchi T
Leukemia; 1999 Sep; 13(9):1399-405. PubMed ID: 10482991
[TBL] [Abstract][Full Text] [Related]
16. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
18. [Tumor necrosis factor alpha enhances apoptosis of all-trans retinoic acid-induced promyelocytic leukemia cells].
Li M; Yang H; Wang C; Yao Z; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):869-72, 878. PubMed ID: 26146052
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
[TBL] [Abstract][Full Text] [Related]
20. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.
Elstner E; Linker-Israeli M; Le J; Umiel T; Michl P; Said JW; Binderup L; Reed JC; Koeffler HP
J Clin Invest; 1997 Jan; 99(2):349-60. PubMed ID: 9006004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
